|
1
|
De A, De A, Sharma R, Suo W and Sharma M:
Sensitization of Carboplatinum- and Taxol-Resistant High-Grade
Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by
Emblica officinalis (Amla) via Multiple Targets. J Cancer.
11:1927–1939. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chua KJC, Patel RD, Trivedi R, Greenberg
P, Beiter K, Magliaro T, Patel U and Varughese J: Accuracy in
Referrals to Gynecologic Oncologists Based on Clinical Presentation
for Ovarian Mass. Diagnostics (Basel). 10:1062020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang D, Gaul DA, Nan H, Kim J and
Fernández FM: Deep Metabolomics of a High-Grade Serous Ovarian
Cancer Triple-Knockout Mouse Model. J Proteome Res. 18:3184–3194.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giampaolino P, Della Corte L, Foreste V,
Vitale SG, Chiofalo B, Cianci S, Zullo F and Bifulco G: Unraveling
a difficult diagnosis: The tricks for early recognition of ovarian
cancer. Minerva Med. 110:279–291. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leskela S, Romero I, Cristobal E,
Pérez-Mies B, Rosa-Rosa JM, Gutierrez-Pecharroman A, Santón A,
Gonzalez BO, López-Reig R, Hardisson D, et al: The Frequency and
Prognostic Significance of the Histologic Type in Early-stage
Ovarian Carcinoma: A Reclassification Study by the Spanish Group
for Ovarian Cancer Research (GEICO). Am J Surg Pathol. 44:149–161.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Della Corte L, Giampaolino P, Fabozzi A,
Cieri M, Zizolfi B, Morra I and Bifulco G: Breast metastasis two
years after pelvic surgery and adjuvant chemotherapy for serous
ovarian cancer. Gynecol Endocrinol. 35:211–213. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Buensuceso A, Ramos-Valdes Y, DiMattia GE
and Shepherd TG: AMPK-Independent LKB1 Activity Is Required for
Efficient Epithelial Ovarian Cancer Metastasis. Mol Cancer Res.
18:488–500. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tato-Varela S and Kuhn W: Impact of
retroperitoneal lymph node dissection in ovarian cancer - time for
paradigm shift? Horm Mol Biol Clin Investig. 41:201900202019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kontomanolis EN, Fasoulakis Z, Papamanolis
V, Koliantzaki S, Dimopoulos G and Kambas NJ: The Impact of
microRNAs in Breast Cancer Angiogenesis and Progression. MicroRNA.
8:101–109. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mucha O, Podkalicka P, Mikulski M, Barwacz
S, Andrysiak K, Biela A, Mieczkowski M, Kachamakova-Trojanowska N,
Ryszawy D, Białas A, et al: Development and characterization of a
new inhibitor of heme oxygenase activity for cancer treatment. Arch
Biochem Biophys. 671:130–142. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grayson K, Gregory E, Khan G and Guinn BA:
Urine Biomarkers for the Early Detection of Ovarian Cancer - Are We
There Yet? Biomark Cancer. 11:1179299X198309772019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stewart D and Cristea M: Antibody-drug
conjugates for ovarian cancer: Current clinical development. Curr
Opin Obstet Gynecol. 31:18–23. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zou X, Zhu D, Zhang H, Zhang S, Zhou X, He
X, Zhu J and Zhu W: MicroRNA expression profiling analysis in serum
for nasopharyngeal carcinoma diagnosis. Gene. 727:1442432020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jain N, Das B and Mallick B: Restoration
of microRNA-197 expression suppresses oncogenicity in fibrosarcoma
through negative regulation of RAN. IUBMB Life. 72:1034–1044. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tani S, Kusakabe R, Naruse K, Sakamoto H
and Inoue K: Genomic organization and embryonic expression of
miR-430 in medaka (Oryzias latipes): Insights into the
post-transcriptional gene regulation in early development. Gene.
449:41–49. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Z, Wang Y, Dou C, Sun L, Li Q, Wang L,
Xu Q, Yang W, Liu Q and Tu K: MicroRNA-1468 promotes tumor
progression by activating PPAR-γ-mediated AKT signaling in human
hepatocellular carcinoma. J Exp Clin Cancer Res. 37:492018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong D, Mu Z, Wei N, Sun M, Wang W, Xin N,
Shao Y and Zhao C: Long non-coding RNA ZFAS1 promotes proliferation
and metastasis of clear cell renal cell carcinoma via targeting
miR-10a/SKA1 pathway. Biomed Pharmacother. 111:917–925. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shirafkan N, Shomali N, Kazemi T,
Shanehbandi D, Ghasabi M, Baghbani E, Ganji M, Khaze V, Mansoori B
and Baradaran B: MicroRNA-193a-5p inhibits migration of human HT-29
colon cancer cells via suppression of metastasis pathway. J Cell
Biochem. Dec 2–2018.(Epub ahead of print). doi:
10.1002/jcb.28164.
|
|
19
|
Chen J, Gao S, Wang C, Wang Z, Zhang H,
Huang K, Zhou B, Li H, Yu Z, Wu J, et al: Pathologically decreased
expression of miR-193a contributes to metastasis by targeting
WT1-E-cadherin axis in non-small cell lung cancers. J Exp Clin
Cancer Res. 35:1732016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and −5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding N, Sun X, Wang T, Huang L, Wen J and
Zhou Y: miR-378a-3p exerts tumor suppressive function on the
tumorigenesis of esophageal squamous cell carcinoma by targeting
Rab10. Int J Mol Med. 42:381–391. 2018.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen Td: Analysis of
relative gene expression data using real-time quantitative Pcr and
the 2(−delta deltac(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hou M, Cheng Z, Shen H, He S, Li Y, Pan Y,
Feng C, Chen X, Zhang Y, Lin M, et al: Correction: High expression
of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is
associated with poor prognosis. Oncotarget. 11:825–826. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie Y, Zhao J, Liang Y, Chen M, Luo Y, Cui
X, Jiang B, Peng L and Wang X: MicroRNA-10b controls the metastasis
and proliferation of colorectal cancer cells by regulating
Krüppel-like factor 4. Artif Cells Nanomed Biotechnol.
47:1722–1729. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu S, Zang R, Wang Y, Liang Y, Mu J, Zhang
Y and Ma J: Highly expressed microRNA-124 inhibits migration and
promotes apoptosis of esophageal cancer cells by degrading PDCD6. J
BUON. 24:805–812. 2019.PubMed/NCBI
|
|
26
|
Yang Y, Zhou L, Lu L, Wang L, Li X, Jiang
P, Chan LK, Zhang T, Yu J, Kwong J, et al: A novel
miR-193a-5p-YY1-APC regulatory axis in human endometrioid
endometrial adenocarcinoma. Oncogene. 32:3432–3442. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Jiang F, He H, Ye J, Mao X, Guo
Q, Wu SL, Zhong W, Wu CL and Lin N: Identification of a novel
microRNA-mRNA regulatory biomodule in human prostate cancer. Cell
Death Dis. 9:3012018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Chen Y, Shen L and Deng Y:
Improvement of membranous nephropathy by inhibition of miR-193a to
affect podocytosis via targeting WT1. J Cell Biochem.
120:3438–3446. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jin L, Li H, Wang J, Lin D, Yin K, Lin L,
Lin Z, Lin G, Wang H, Ying X, et al: MicroRNA-193a-5p exerts a
tumor suppressor role in glioblastoma via modulating NOVA1. J Cell
Biochem. 120:6188–6197. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Z, Chen JS, Wen JK, Gao HT, Zheng B,
Qu CB, Liu KL, Zhang ML, Gu JF, Li JD, et al: Silencing of
miR-193a-5p increases the chemosensitivity of prostate cancer cells
to docetaxel. J Exp Clin Cancer Res. 36:1782017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Finetti F, Moglia A, Schiavo I, Donnini S,
Berta GN, Di Scipio F, Perrelli A, Fornelli C, Trabalzini L and
Retta SF: Yeast-Derived Recombinant Avenanthramides Inhibit
Proliferation, Migration and Epithelial Mesenchymal Transition of
Colon Cancer Cells. Nutrients. 10:11592018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stepien A, Knop K, Dolata J, Taube M,
Bajczyk M, Barciszewska-Pacak M, Pacak A, Jarmolowski A and
Szweykowska-Kulinska Z: Posttranscriptional coordination of
splicing and miRNA biogenesis in plants. Wiley Interdiscip Rev RNA.
May 8–2017.(Epub ahead of print). doi: 10.1002/wrna.1403.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Movafagh S, Crook S and Vo K: Regulation
of hypoxia-inducible factor-1a by reactive oxygen species: New
developments in an old debate. J Cell Biochem. 116:696–703. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sideris M and Papagrigoriadis S: Molecular
biomarkers and classification models in the evaluation of the
prognosis of colorectal cancer. Anticancer Res. 34:2061–2068.
2014.PubMed/NCBI
|
|
35
|
Maroof H, Salajegheh A, Smith RA and Lam
AK: Role of microRNA-34 family in cancer with particular reference
to cancer angiogenesis. Exp Mol Pathol. 97:298–304. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang MJ, Xu YY, Huang RY, Chen XM, Chen
HM, Han L, Yan YH and Lu CJ: Role of an imbalanced miRNAs axis in
pathogenesis of psoriasis: Novel perspectives based on review of
the literature. Oncotarget. 8:5498–5507. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin CH, Tsai CH, Yeh CT, Liang JL, Hung
WC, Lin FC, Chang WL, Li HY, Yao YC, Hsu TI, et al:
MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response
indicator of esophageal squamous cell carcinoma. Oncotarget.
7:39680–39693. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoshitake Y, Nakatsura T, Monji M, Senju
S, Matsuyoshi H, Tsukamoto H, Hosaka S, Komori H, Fukuma D, Ikuta
Y, et al: Proliferation potential-related protein, an ideal
esophageal cancer antigen for immunotherapy, identified using
complementary DNA microarray analysis. Clin Cancer Res.
10:6437–6448. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Moela P, Choene MM and Motadi LR:
Silencing RBBP6 (Retinoblastoma Binding Protein 6) sensitises
breast cancer cells MCF7 to staurosporine and camptothecin-induced
cell death. Immunobiology. 219:593–601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Motadi LR, Bhoola KD and Dlamini Z:
Expression and function of retinoblastoma binding protein 6 (RBBP6)
in human lung cancer. Immunobiology. 216:1065–1073. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Moela P and Motadi LR: RBBP6: A potential
biomarker of apoptosis induction in human cervical cancer cell
lines. OncoTargets Ther. 9:4721–4735. 2016. View Article : Google Scholar : PubMed/NCBI
|
